Protein reconstitution into vesicles
For acceptor vesicles containing t-SNAREs, 60 ml of Vam3 (2.9 mg ml -1 ), 200 ml of His 6 ± Vam7 (8.2 mg ml -1 ) and/or 20 ml of His 6 ±Vti1 (14 mg ml -1 ) were mixed and 20 ml of 10% octyl-b-D-glucopyranoside and 250 ml of reconstitution buffer were added. After incubation at 4 8C for 20 h, 500 ml of the reaction was used for reconstitution of acceptor vesicles. For donor vesicles containing the v-SNARE, 100 ml of GST±Nyv1 (3.6 mg ml -1 ) was used. SNAREs were reconstituted as described 2 except that all the buffers used for reconstitution contained 500 mM KCl. The principal lipid components in the liposomes were 85% DOPC (1,2-dioleoyl phosphatidylcholine) and 15% DOPS (1,2-dioleoyl phosphatidylserine). Typical lipid concentration in the recovered Nycodenz fractions containing the vesicles were 0.7±0.9 mM for donor vesicles and 1.8±2.5 mM for acceptor vesicles. Concentrations of GST±Nyv1 in donor vesicle fractions were 0.7±0.8 mg ml -1 and those of t-SNARE complex in acceptor vesicles were 0.45±0.5 mg ml -1 , corresponding to a 16% and 9% reconstitution ef®ciency. For preparation of vesicles containing vacuolar lipids 29, 30 , we used the following lipid mixture: DOPC (1,2-dioleoyl phosphatidylcholine)/ DOPE (1,2-dioleoyl phosphatidylethanolamine)/ soybean PI (phosphatidylinositol)/ DOPS (1,2-dioleoyl phosphatidylserine)/ DOPA (1,2-dioleoyl phosphatidic acid)/ heart cardiolipin in a 53:20:19:5:2:1 molar ratio. All lipids were obtained from Avanti Polar Lipids. The reconstitution ef®ciencies for v-SNAREs and t-SNAREs in vacuolar lipid mixtures were 8% and 9%, respectively.
Lipid mixing assay
Lipid mixing assay was carried out as described 2, 15 , except that n-dodecylmaltoside was used to determine the maximum NBD signal instead of Triton X-100. Rounds of fusion were determined by using a calibration curve which was prepared as described 16 , except that GST±Nyv1 was used instead of VAMP to reconstitute vesicles and that the mixtures of labelled and unlabelled lipids corresponded to one-, two-, three-, four-, or sixfold dilutions of donor¯uorescent lipid. The equation used to convert the percentage dodecylmaltoside signal to rounds of fusion is y = (0.52247´e (0.032993x) ) -(0.527´e (-0.074915x) ) where y is the rounds of fusion and x is the percentage dodecylmaltoside signal at a given time interval.
Insulin stimulates the transport of glucose into fat and muscle cells. Although the precise molecular mechanisms involved in this process remain uncertain, insulin initiates its actions by binding to its tyrosine kinase receptor, leading to the phosphorylation of intracellular substrates. One such substrate is the Cbl protooncogene product 1 . Cbl is recruited to the insulin receptor by interaction with the adapter protein CAP, through one of three adjacent SH3 domains in the carboxy terminus of CAP 2 . Upon phosphorylation of Cbl, the CAP±Cbl complex dissociates from the insulin receptor and moves to a caveolin-enriched, tritoninsoluble membrane fraction 3 . Here, to identify a molecular mechanism underlying this subcellular redistribution, we screened a yeast two-hybrid library using the amino-terminal region of CAP and identi®ed the caveolar protein¯otillin. Flotillin forms a ternary complex with CAP and Cbl, directing the localization of the CAP±Cbl complex to a lipid raft subdomain of the plasma membrane. Expression of the N-terminal domain of CAP in 3T3-L1 adipocytes blocks the stimulation of glucose transport by insulin, without affecting signalling events that depend on phosphatidylinositol-3-OH kinase. Thus, localization of the Cbl±CAP complex to lipid rafts generates a pathway that is crucial in the regulation of glucose uptake.
To identify proteins that may participate in the localization and function of Cbl and CAP, we screened a yeast two-hybrid library derived from 3T3-L1 adipocytes 4 using as bait the N-terminal region of CAP, which contains the sorbin homology domains but lacks the SH3 domains (CAPDSH3, Fig. 1a ). Three independent clones were isolated encoding the protein¯otillin 5 . To examine the binding speci®city of¯otillin and CAP, we incubated glutathione-Ssepharose-bound¯otillin (GST±¯otillin) with lysates from human embryonic kidney (HEK293T) cells overexpressing either Flagepitope-tagged full-length CAP or Flag-epitope-tagged CAPDSH3. As seen in Fig. 1b , GST±¯otillin bound to both Flag±CAP and Flag± CAPDSH3. It also precipitated endogenous Cbl from the extracts in the presence of CAP but not when CAPDSH3 was co-expressed. These data indicate that the interaction of¯otillin with Cbl requires full-length CAP to form a¯otillin±CAP±Cbl ternary complex.
Triton-insoluble microdomains of the plasma membrane have been implicated in signal transduction 6, 7 . Flotillin is an integral membrane protein that associates with the triton-insoluble fraction enriched in the caveolar protein caveolin 5 . Moreover,¯otillin can physically associate in hetero-oligomeric structures with caveolin in detergent-solubilized cells 8 . The physiochemical properties of proteins that are enriched in lipid rafts make it dif®cult to perform standard, triton-soluble, co-immunoprecipitation assays. We therefore examined the subcellular localization of CAP, CAPDSH3, endogenous caveolin and¯otillin by confocal immuno¯uorescence microscopy of intact cells and by immuno¯uorescence following preparation of plasma membrane sheets. After transfection of 3T3-L1 adipocytes by electroporation 9 , both Flag±CAP and Flag± CAPDSH3 showed diffuse staining of the cytoplasm, with a signi®cant portion found nonuniformly distributed around the plasma membrane (see Supplementary Information Fig. 1 ). Immunostaining of endogenous caveolin followed by a Texas Red secondary antibody revealed caveolin in the plasma membrane, as reported 6, 7 . Merging the two images shows that a signi®cant portion of both CAP and CAPDSH3 proteins are found at the plasma membrane, similar to the endogenous caveolin I.
To examine the plasma membrane localization of caveolin in relation to¯otillin, we prepared plasma membrane sheets from 3T3-L1 adipocytes and immunostained them with antibodies to caveolin and¯otillin. Caveolin and¯otillin were localized together in circular rosette structures in the plasma membrane (see Supplementary Information Fig. 2 ). The co-distribution of¯otillin and caveolin in the plasma membrane was unaffected by insulin stimulation. These¯otillin and caveolin-enriched structures probably consist of collections of caveolae or lipid rafts 10 .
To investigate further the dynamics of endogenous Cbl protein association with¯otillin, we took a similar approach using immunouorescence of isolated plasma membrane sheets (Fig. 2) . As described above, exposure of cells to insulin for 2±60 min had no effect on the overall plasma membrane distribution of¯otillin. Although Cbl was not detected in the plasma membrane sheets in the basal state, there was transient translocation of Cbl to the plasma membrane, which was apparent after 2 and 5 min of insulin stimulation. This time-dependent translocation of Cbl to the plasma membrane is similar to the time course of insulin-stimulated Cbl tyrosine phosphorylation 11 . Furthermore, merging of these images showed that Cbl localized with¯otillin in rosette-type structures, again suggesting the insulin-dependent formation of a ternarȳ otillin±CAP±Cbl complex. Finally, to assess biochemically the relationship between caveolin, otillin and Cbl, we subjected basal and insulin-stimulated 3T3-L1 adipocytes to non-detergent homogenization and sucrose gradient fractionation (see Supplementary Information Fig. 3 ). Consistent with the immuno¯uorescence of isolated plasma membrane sheets, caveolin was found primarily in the low-density membrane regions of these gradients (fractions 3 and 4), and was not affected by insulin treatment. Similarly,¯otillin was found in the fractions containing caveolin. Cbl was primarily con®ned to the dense regions of the gradient (fractions 8±12) in the basal state. However, following insulin stimulation, a portion of the Cbl protein was redistributed to the low-density fractions containing caveolin and¯otillin. Together, these data provide strong evidence that caveolin and¯otillin are colocalized in distinct subdomains of the plasma membrane, and that insulin induces the translocation of Cbl to these caveolin-and otillin-enriched compartments through its interaction with CAP.
To assess the potential role of CAP in early signalling events, we next overexpressed CAP or CAPDSH3 in 3T3-L1 adipocytes and evaluated insulin-stimulated tyrosine phosphorylation. Both proteins were found in the triton-soluble and insoluble fractions (Fig. 3a) , and expressed at levels around ®vefold higher than the endogenous CAP protein (data not shown). Expression of CAP or CAPDSH3 had no effect on the tyrosine phosphorylation of the insulin receptor b-subunit or its predominant substrate, IRS-1 (Fig. 3b) . Similarly, there was no change in the ability of insulin to stimulate the phosphorylation of two downstream targets, AKT/ protein kinase B and mitogen-activated protein kinase (MAPK), that are activated as a consequence of well characterized phosphorylation cascades (Fig. 3b) . As AKT activation occurs as a direct consequence of phosphatidylinositol-3-OH kinase (PI(3)K) stimulation 12 , these data also show that the expression of CAPDSH3 did not affect the stimulation of PI(3)K activity by insulin. the protein to the insulin receptor by CAP 2 . As CAPDSH3 does not bind either Cbl or the insulin receptor, overexpression of CAP or CAPDSH3 had no effect on insulin-stimulated Cbl phosphorylation in the triton-soluble fraction (Fig. 3c) . However, CAPDSH3 overexpression signi®cantly reduced the appearance of tyrosine phosphorylated Cbl in the triton-insoluble fraction (Fig. 3d) . These data indicate that the expression of the N-terminal¯otillin-binding domain of CAP may be able to block the interaction of the endogenous CAP±Cbl complexes with¯otillin, thus preventing the appearance of phosphorylated Cbl in the triton-insoluble plasma membrane subdomain.
To investigate the role of the association of the CAP±Cbl complex with¯otillin in insulin action, we evaluated the effect of CAPDSH3 expression on insulin-stimulated [ 14 C]2-deoxyglucose uptake in 3T3-L1 adipocytes (Fig. 4a) . Although wild-type CAP had no effect, expression of CAPDSH3 led to a reduction of about 50% in insulinstimulated glucose uptake, without affecting basal activity. Similar experiments were done to evaluate the effect of LacZ, CAP or CAPDSH3 on glycogen and lipid synthesis (Fig. 4b, c) . As observed for glucose uptake, the expression of CAPDSH3 inhibited the insulin-stimulated incorporation of [ 14 C]glucose into glycogen and lipid, whereas expression of CAP had no effect. Considering that the average ef®ciency of transfection by electroporation in these cells is about 50% (ref. 9), the observed reduction in glucose utilization may indicate that the expression of the CAPDSH3 mutant almost completely blocked the metabolic actions of insulin. The stimulation of glucose uptake and utilization by insulin is dependent upon the translocation of the insulin-responsive glucose transporter GLUT4 from intracellular storage sites to the plasma membrane. To investigate how CAPDSH3 blocks glucose transport, the translocation of GLUT4 was directly examined. We electroporated 3T3-L1 adipocytes with pcDNA3, CAP or CAPDSH3 together with a construct encoding an enhanced green¯uorescent protein fusion of GLUT4 (GLUT4±EGFP; Fig. 5a ). As expected, insulin stimulated the translocation of GLUT4±EGFP to the plasma membrane in cells transfected with pcDNA3 or CAP, as detected by the presence of a continuous rim of cell-surface EGFP¯uorescence. In contrast, expression of CAPDSH3 markedly inhibited GLUT4± EGFP translocation to the cell surface in response to insulin. Expression of CAPDSH3 not only decreased the number of cells displaying GLUT4±EGFP at the cell surface, but also decreased the plasma membrane intensity in those cells that still had observable rim¯uorescence (arrows). Quanti®cation of the number of transfected cells displaying any visual rim¯uorescence indicated that following pcDNA3 or wild-type CAP transfection, about 65% of the cells displayed insulin-stimulated translocation, which was reduced to less than 30% in cells transfected with CAPDSH3.
The insulin-responsive aminopeptidase (IRAP) is localized in the same compartments as GLUT4 in adipocytes, and undergoes an identical pattern of insulin-stimulated translocation 13, 14 . As expected, expression of CAPDSH3 blocked insulin-stimulated translocation of EGFP±IRAP, in a manner identical to that observed with EGFP±GLUT4 (Fig. 5c ). Insulin also stimulates the net exocytosis of the cation-independent mannose-6-phosphate/IGF-2 receptor (CI/MPR). This protein is located in compartments distinct from the GLUT4/IRAP-containing vesicles, and travels between the trans-Golgi network and the late endosomes in the absence of insulin 15±17 . Expression of CAPDSH3 had no signi®cant effect on the insulin-stimulated translocation of a CI/MPR±EGFP fusion protein (Fig. 5d) , in contrast to its effects on GLUT4 and IRAP.
As the determination of translocation in these intact cell assays relies on the qualitative strength of plasma membrane rim¯uores-cence from overexpressed EGFP-fusion proteins, we also examined the translocation of the endogenous GLUT4 and GLUT1 proteins in isolated plasma membrane sheets from microinjected 3T3-L1 adipocytes (Fig. 6) . To identify the plasma membrane sheets derived from the microinjected cells, the wild-type CAP and CAPDSH3 complementary DNAs were microinjected into the cells with the maltose-binding protein (MBP)-Ras cDNA 18 . In the absence of insulin, microinjection of MBP-Ras and CAPDSH3 resulted in the identi®cation of four MBP-Ras positive sheets in the ®elds shown in Fig. 6 (arrows) .
In the absence of insulin, GLUT4 remained intracellular, with low levels of plasma membrane GLUT4 in both the microinjected and surrounding non-microinjected cells. Insulin stimulation resulted in the appearance of GLUT4 at the plasma membrane in the nonmicroinjected cells, but not in the cells microinjected with CAPDSH3. In contrast, microinjection of cells with the wild-type CAP cDNA had no signi®cant effect on GLUT4 translocation, compared with the surrounding non-microinjected cells. Quanti®-cation of these data showed that insulin stimulated the translocation of GLUT4 in 87 6 6% of the cells microinjected with wild-type CAP. In contrast, expression of CAPDSH3 resulted in a marked reduction, with only 28 6 10% of the plasma membrane sheets displaying any detectable GLUT4 translocation.
Like CI/MPR, the GLUT1 glucose transporter resides in vesicle compartments distinct from GLUT4, and undergoes modest insulin-stimulated plasma membrane translocation 19 . To assess the speci®city of CAPDSH3, we examined the translocation of the endogenous GLUT1 protein in microinjected 3T3-L1 adipocytes (see Supplementary Information Fig. 4) . Insulin modestly stimulated the translocation of GLUT1. However, this effect of insulin was not impaired by the microinjection of either wild-type CAP or CAPDSH3 cDNAs. Under these conditions, 94 6 2% and 87 6 6% of the cells microinjected with wild-type CAP and CAPDSH3, respectively, displayed insulin-stimulated GLUT1 translocation. Together, these data show that the CAPDSH3 mutant has a dominant-interfering effect on insulin-stimulated translocation of GLUT4/IRAP-containing vesicles to the plasma membrane, without affecting general exocytosis or other insulin-regulated vesicle traf®cking processes.
The stimulation of glucose transport by insulin is a complex, multistep process involving the movement of intracellularly sequestered GLUT4-containing vesicles to the cell surface, followed by docking and fusion with the plasma membrane 19 . The activation of PI(3)K and its downstream kinases AKT and/or protein kinase Cz/l (PKCz/l) are required for this process, as inhibitors and dominant-negative mutants of PI(3)K, AKT and PKCz/l can completely block insulin-stimulated glucose transport 20 . There is compelling evidence, however, that activation of PI(3)K-dependent pathways is not suf®cient to induce glucose transport. Other growth factors and adhesion molecules that can activate PI(3)K and its downstream kinases have no effect on glucose transport or GLUT4 translocation 21±23 . Furthermore, cell-permeable derivatives of phosphatidylinositol 3,4,5-trisphosphate can stimulate GLUT4 translocation only when cells are pre-treated with insulin 24 . These data suggest that insulin must generate at least two independent signals to stimulate glucose transport, one dependent on and another independent of PI(3)K.
What is the second signal needed for insulin-stimulated glucose transport? Our data indicate that this pathway is probably initiated by the phosphorylation of Cbl and its subsequent segregation into lipid raft subdomains of the plasma membrane. This process is independent of wortmannin (data not shown) and requires the adapter protein CAP 2 . CAP expression and Cbl phosphorylation correlate well with insulin sensitivity 25 . The appearance of phosphorylated Cbl in the triton-insoluble fraction, its association with the src kinase fyn, and the subsequent phosphorylation of the caveolar protein caveolin are speci®cally stimulated by insulin. Insulin-stimulated Cbl tyrosine phosphorylation is observed only in insulin-sensitive cells and tissues in which CAP is also expressed 1, 3, 11 . Although inhibition of Cbl phosphorylation in the triton-insoluble complexes with the CAPDSH3 mutant does not interfere with PI(3)K-dependent and ras-dependent signalling, disruption of this association markedly attenuates insulin-stimulated GLUT4 translocation and glucose uptake. Whether the GLUT4 protein itself resides in the triton-insoluble microdomains of the plasma membrane remains uncertain 26±28 . However, it is possible that the association of the CAP±Cbl complex with other proteins in lipid rafts may lead to the segregated generation of a speci®c signal, perhaps directing fusion of the GLUT4 vesicle to the plasma membrane in a domain near the lipid raft.
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Methods
Cell culture and transfection of HEK293Tcells and 3T3-L1 adipocytes HEK293T cells were maintained in Dulbecco's Eagle Medium (DMEM) containing 10% fetal bovine serum at 37 8C and 5% CO 2 . HEK293T cells were transfected with a mammalian CaPO 4 transfection kit as described by the manufacturer (Stratagene). 3T3-L1 preadipocytes were cultured in DMEM containing 25 mM glucose, 10% calf serum at 37 8C and 5% CO 2 . Con¯uent cultures were induced to differentiate into adipocytes as described 29 . 3T3-L1 adipocytes were transiently transfected by electroporation as described 9 . The cells were then allowed to adhere to collagen-coated tissue culture dishes for 30±48 h before serum starvation and insulin treatment. The average ef®ciency of transfection was 50% as evaluated by b-galactosidase staining.
In vitro protein associations
The Flag±CAP expression construct was made as described 2 . We constructed Flagepitope-tagged CAPDSH3 by restriction digestion, removal of the SH3 domains of the CAP cDNA and religation of the CAP expression construct. CAPDSH3 does not associate with Cbl or the insulin receptor. We lysed HEK293T cells overexpressing CAP or CAPDSH3 in HNTG buffer containing protease inhibitors and sodium orthovanadate 29 . Lysates from HEK293T cells were incubated with GST alone or GST±¯otillin immobilized on glutathione agarose beads for 1 h at 4 8C. Beads were then washed extensively with HNTG and retained proteins were eluted in 4´Laemmli sample buffer, heated for 5 min at 100 8C, separated by SDS±PAGE and immunoblotted with either a Flag antibody (Stratagene) or a polyclonal c-Cbl antibody (Santa Cruz).
GLUT4-EGFP, IRAP-EGFP and CI/M6PR-EGFP translocation assays
We constructed all EGFP fusion proteins and performed translocation assays as described 9 . Brie¯y, 3T3-L1 adipocytes were electroporated with 50 mg of the EGFP-tagged plasmid and 200 mg of empty vector, CAP or CAPDSH3 constructs. Adipocytes were replated, allowed to recover overnight and stimulated with or without 100 nM insulin for 30 min. The cells were then ®xed and EGFP¯uorescence was analysed by confocal immunouorescence microscopy.
Single cell microinjection and plasma membrane sheet isolation
We grew 3T3-L1 adipocytes on 35-mm tissue culture dishes. Before microinjection, the medium was changed to Lebovitz's L-15 medium containing 0.1% bovine serum albumin and microinjection was carried out as described 30 . The cells were allowed to recover for 24 h and plasma membrane sheets were prepared as described 18 . The bound plasma membranes sheets were then subjected to confocal¯uorescent microscopy.
Metabolic assays
We determined 2-deoxyglucose uptake, glycogen synthesis and lipogenesis as described 29 .
Immunoprecipitations and immunoblotting
After insulin treatment, we washed electroporated adipocytes with PBS and lysed them in MBS buffer containing protease inhibitors and sodium orthovanadate. Lysed cells were kept at 4 8C to prevent degradation of caveolar complexes. The triton-insoluble pellet fraction was generated as described 11 . This triton-insoluble pellet fraction was solubilized in SOL buffer containing protease inhibitors and sodium orthovanadate as described 11 . Lysates and immunoprecipitations were resolved by SDS±PAGE and transferred to nitrocellulose for immunoblot analysis.
Immunoprecipitations were performed using a polyclonal c-Cbl antisera (Santa Cruz). We used monoclonal 4G10 anti-phosphotyrosine antibodies (Upstate Biotechnology) to blot for IR, IRS-1 and Cbl tyrosine phosphorylation. Polyclonal phospho-AKT and phospho-MAPK antibodies (New England Biolabs) were used to probe for activated AKT and MAP kinase. Monoclonal caveolin I antibodies (Transduction Labs) were used to evaluate protein content of the resolved TIP fractions. We used horseradish peroxidase (HRP)-conjugated secondary antibodies and ECL chemiluminesence for immunoblot detection.
